Pj. Bosma et al., THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME, The New England journal of medicine, 333(18), 1995, pp. 1171-1175
Background. People with Gilbert's syndrome have mild, chronic unconjug
ated hyperbilirubinemia in the absence of liver disease or overt hemol
ysis. Hepatic glucuronidating activity, essential for efficient biliar
y excretion of bilirubin, is reduced to about 30 percent of normal. Me
thods. We sequenced the coding and promoter regions of the gene for bi
lirubin UDP-glucuronosyltransferase 1 (bilirubin/uridine diphosphogluc
uronate-glucuronosyltransferase 1) - the only enzyme that contributes
substantially to bi[irubin glucuronidation - in 10 unrelated patients
with Gilbert's syndrome, 16 members of a kindred with a history of Cri
gler-Najjar syndrome type II, and 55 normal subjects. Results. The cod
ing region of the gene for the enzyme was normal in the 10 patients wi
th Gilbert's syndrome. These patients were homozygous for two extra ba
ses (TA) in the TATAA element of the 5' promoter region of the gene (A
(TA)(7)TAA rather than the normal A(TA)(6)TAA). The presence of the. l
onger TATAA element resulted in the reduced expression of a reporter g
ene, encoding firefly luciferase, in a human hepatoma cell line. The f
requency of the abnormal allele was 40 percent among the normal subjec
ts. The 3 men in the control group who were homozygous for the longer
TATAA element had significantly higher serum bilirubin levels than the
other 52 normal subjects (P = 0.009). Among the kindred with a histor
y of Crigler-Najjar syndrome type II, only the six heterozygous carrie
rs who had a longer TATAA element on the structurally normal allele ha
d mild hyperbilirubinemia, characteristic of Gilbert's syndrome. Concl
usions. Reduced expression of bilirubin UDP-glucuronosyltransferase 1
due to an abnormality in the promoter region of the gene for this enzy
me appears to be necessary for Gilbert's syndrome but not sufficient f
or the complete manifestation of the syndrome.